期刊文献+

基于磁珠处理的MALDI-TOF实验技术优化 被引量:2

Optimization of Approach to Proteome Profiling of Human Serum Based on Magnetic Bead Separation and MALDI-TOF MS
下载PDF
导出
摘要 目的:利用基质辅助激光解析离子化飞行时间质谱(matrix-assisted laser desorption/ionization timeofflight mass spectrometry,MALDI-TOFMS)技术检测血清中蛋白,目前常用磁珠来分离提纯,本研究目的是寻找一套有效的血清样品收集、处理、存储方法,应用于蛋白组学分析。方法:采用磁珠分离提纯人体血清,利用MALDI-TOF技术检测1000-10000Da范围蛋白或多肽,考察其重复性及血清不同的冻融次数和基质与样品搭配比例对结果的影响。结果:人类血清的质谱图在1000~10000Da范围内可检测到230多个峰.重复性极好。样品多次冻融对小分子量的多肽有一定影响。在适当范围内改变样品与基质比例对结果无影响。结论:基于磁珠分离提纯的MALDI-TOF技术在应用于人体血清检测时应用标准化程序可以减少变异。 Objective:Magnetic bead purification for the analysis of proteins in human blood serum facilitates the identification of potential new biomarkers with matrix-assisted laser desorption/ionization time-offlight mass spectrometry(MALDI-TOF MS). The purpose of the study was to establish a proteome fractionation technique and to validate a standardized blood sampling, processing,and storage procedure for proteomic pattern analysis. Methods: Magnetic bead separation was used for proteome profiling of human blood by MAL- DI-TOF MS(mass range, 1 000-10 000 Da)and the effects on the reproducibility of the proteome analysis of the number of freeze-thaw cycles of samples and ratio of sample and matrix were studied. Results, The proteome pattern of human serum was characterized by 230 signals in the mass range of 1 000-10 000 Da. Serum mass patterns differed between samples in different freeze-thaw cycles,espeaially in low-weight molecule peptides. Different ratios of sample and matrix showed no effects on proteome profiling. Conclusion:Application of the standardized preanalytical blood sampling and storage procedure in combination with magnetic bead-based fraction decreases variability of proteome patterns in human serum assessed by MALDI-TOF MS.
出处 《河北北方学院学报(医学版)》 2008年第5期1-4,共4页 Journal of Hebei North University:Medical Edition
基金 河北省卫生厅医学科学研究重点课题计划(编号:05276101D-86)
关键词 蛋白质组学 磁珠疗法 基质辅助 激光解析离子化飞行时间质谱 Proteomics, Magnetic Bead Therapy, MALDI-TOF MS
  • 相关文献

参考文献15

  • 1Etzioni R,Urban N,Ramsey S,et al. The case for early detection[J]. Nat Rev Cancer, 2003,3: 243-252
  • 2Aldred S, Grant MM, Griffiths HR. The use of proteomies for the assessment of clinical samples in research[J]. Clin Biochem, 2004,37 :943-952
  • 3Diamandis EP. Proteomic patterns in serum and identification of ovarian cancer [Letter][J]. Lancet, 2002,360:170
  • 4Guillaume E, Zimmermann C, Burkhard PR, et al. A potential cerebrospinal fluid and plasmatic marker for the diagnosis of Creutzfeldt-Jakob disease [ J ]. Proteomics, 2003, 3: 1495-1499
  • 5Howard BA, Wang MZ, Campa MJ, et al. Identification and validation of a potential lung cancer serum biomarker detected by matrix-assisted laser desorption/ionization- time of flight spectra analysis[J]. Proteomics, 2003 , 3 : 1720-1724
  • 6Koopmann J, Zhang Z, White N, et al. Serum diagnosis of pancreatic adenocarcinoma using surface-enhanced laser desorption and ionization mass spectrometry [J]. Clin Cancer Res, 2004,10 : 860-868
  • 7Menon U, Jacobs I. Screening for ovarian cancer [J]. Best Pratt Res Clin Obstet. Gynaecol, 2002,16 : 469-482
  • 8Petricoin EF, Ardekani AM, Hitt BA, et al. Use of proteomic patterns in serum to identify ovarian cancer[J]. Lancet, 2002,359 : 572-577
  • 9Zheng PP, Luider TM, Pieters R, et al. Identification of tumor-related proteins by proteomic analysis of cerebrospinal fluid from patients with primary brain tumors[J]. J Neuropathol Exp Neurol, 2003,62 : 855-862
  • 10Diamandis EP. Mass spectrometry as a diagnostic and a cancer biomarker discovery tool:opportunities and potential limitations[J]. Mol Cell Proteomics, 2004,3 : 367-378

同被引文献31

引证文献2

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部